Swiss National Bank - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$187,000
+32.6%
40,4000.0%0.00%
Q4 2018$141,000
-65.4%
40,4000.0%0.00%
Q3 2018$407,000
+39.4%
40,4000.0%0.00%
Q2 2018$292,000
+19.7%
40,4000.0%0.00%
Q1 2018$244,000
-29.3%
40,400
+12.5%
0.00%
Q4 2017$345,000
+8.2%
35,9000.0%0.00%
Q3 2017$319,000
-29.7%
35,9000.0%0.00%
-100.0%
Q2 2017$454,000
+20.4%
35,9000.0%0.00%
Q1 2017$377,000
+14.2%
35,9000.0%0.00%
-100.0%
Q4 2016$330,000
-22.0%
35,9000.0%0.00%0.0%
Q3 2016$423,000
-18.5%
35,900
-10.5%
0.00%0.0%
Q2 2016$519,000
-24.3%
40,100
-9.5%
0.00%0.0%
Q1 2016$686,000
-34.5%
44,300
+21.0%
0.00%
-66.7%
Q4 2015$1,048,000
+0.6%
36,6000.0%0.00%0.0%
Q3 2015$1,042,000
-9.3%
36,600
+14.4%
0.00%0.0%
Q2 2015$1,149,000
+27.5%
32,000
+106.5%
0.00%
+50.0%
Q1 2015$901,000
+38.0%
15,5000.0%0.00%0.0%
Q4 2014$653,000
+14.6%
15,500
+5.4%
0.00%0.0%
Q3 2014$570,000
+24.2%
14,7000.0%0.00%0.0%
Q2 2014$459,000
+60.5%
14,700
+113.0%
0.00%
+100.0%
Q1 2014$286,000
+130.6%
6,900
+115.6%
0.00%
Q4 2013$124,0003,2000.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders